ELINZANETANT dipharma_paola2026-09-09T14:08:17+00:00September 9th, 2026| Therapeutic class: Neurokinin NK1 and NK3 Receptor Antagonist CAS number: 929046-33-3 Regulatory status: – Manufactured at: –